ADIAL PHARMACEUTICALS, INC. — Form 8-K
Filed August 25, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
ADIAL Pharmaceuticals filed an 8-K on 2026-08-25 reporting unregistered sales of equity securities (Item 3.02). The filing header provides no dollar amounts, share counts, pricing, counterparty names, or transaction dates beyond the filing date of 2026-08-19. The actual transaction details are not disclosed in the accessible text provided.
Why this rating
Unregistered equity issuance is material for a $6.5M company if material-sized, but specifics missing. Cannot assess without amounts.
Extracted items
See more from August 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.